Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Exploring the association between lifetime traumatic experiences and positive psychotic symptoms in a group of long-stay patients with schizophrenia: the mediating effect of depression, anxiety, and distress.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: Positive psychotic symptoms of schizophrenia are generally characterized by hallucinations and delusions. We propose to assess the relationship between total composite trauma and positive psychotic symptoms, along with the mediation effect of cognition, fear of COVID-19, insomnia, anxiety, distress, and depression of Lebanese patients with schizophrenia.
      Methods: A cross-sectional study was carried out, between June and July 2021, by deriving data from 155 long-stay in-patients diagnosed with schizophrenia.
      Results: Depression, anxiety, and distress but not cognitive impairment, insomnia, and fear of COVID-19) mediated the association between lifetime traumatic experiences and positive psychotic symptoms. Higher traumatic experiences were associated with greater depression, anxiety, and distress, indicating a significant positive total effect on positive psychotic scores. Moreover, higher depression, anxiety, and distress were significantly associated with higher positive psychotic symptoms.
      Conclusion: Our results contribute to the existing knowledge by suggesting other possible intervention paths through mediating factors. Interventions that improve anxiety, depression, and distress severity may be effective in reducing positive psychotic symptoms among patients with schizophrenia having experienced lifetime trauma.
      (© 2023. The Author(s).)
    • References:
      Nature. 2010 Nov 11;468(7321):203-12. (PMID: 21068828)
      Schizophr Res. 2012 Apr;136(1-3):104-9. (PMID: 22104139)
      Aging Ment Health. 2019 May;23(5):551-557. (PMID: 29424560)
      J Abnorm Psychol. 2013 Feb;122(1):180-94. (PMID: 22686871)
      JAMA Psychiatry. 2020 Feb 1;77(2):201-210. (PMID: 31664453)
      J Addict Dis. 2011 Jul-Sep;30(3):216-28. (PMID: 21745044)
      Schizophr Bull. 2012 Jun;38(4):661-71. (PMID: 22461484)
      Lancet. 2016 Jul 2;388(10039):86-97. (PMID: 26777917)
      Sleep Disord. 2013;2013:394320. (PMID: 23819057)
      Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534. (PMID: 32110026)
      Child Adolesc Psychiatr Clin N Am. 2020 Jan;29(1):115-129. (PMID: 31708041)
      PLoS One. 2017 Jan 20;12(1):e0170178. (PMID: 28107388)
      Depress Res Treat. 2015;2015:650804. (PMID: 26693349)
      Gen Psychiatr. 2022 Jan 27;35(1):e100659. (PMID: 35146333)
      Clin Psychol Rev. 2007 May;27(4):409-24. (PMID: 17222489)
      Schizophr Bull. 2020 Jul 8;46(4):752-757. (PMID: 32343342)
      World Psychiatry. 2019 Jun;18(2):162-163. (PMID: 31059615)
      Schizophr Bull. 2017 Mar 1;43(2):240-244. (PMID: 27421793)
      Brain Behav. 2020 Dec;10(12):e01870. (PMID: 33001585)
      Br J Psychiatry. 2015 Jul;207(1):23-9. (PMID: 25953892)
      Psychiatr Danub. 2017 Dec;29(4):480-489. (PMID: 29197206)
      J Affect Disord. 2021 Mar 15;283:179-191. (PMID: 33561798)
      Early Interv Psychiatry. 2017 Aug;11(4):322-333. (PMID: 25808607)
      Nat Sci Sleep. 2017 Sep 21;9:227-239. (PMID: 29033618)
      Curr Opin Psychiatry. 2021 May 1;34(3):203-210. (PMID: 33587494)
      Int J Ment Health Addict. 2022;20(3):1537-1545. (PMID: 32226353)
      Br J Psychiatry. 2011 Jul;199(1):29-37. (PMID: 21508437)
      Front Psychiatry. 2019 Nov 08;10:808. (PMID: 31780969)
      Encephale. 2018 Nov;44(5):397-402. (PMID: 29307705)
      Front Psychiatry. 2017 Mar 06;8:33. (PMID: 28321193)
      Schizophr Res Cogn. 2020 May 19;21:100179. (PMID: 32461919)
      BJPsych Open. 2021 Jan 12;7(1):e35. (PMID: 33431109)
      Psychol Med. 2010 Oct;40(10):1627-34. (PMID: 19995476)
      Schizophr Res Cogn. 2021 May 21;25:100199. (PMID: 34094889)
      Epidemiol Psychiatr Sci. 2016 Aug;25(4):349-59. (PMID: 26156083)
      Indian J Psychol Med. 2012 Oct;34(4):306-12. (PMID: 23723536)
      Schizophr Bull. 2011 May;37(3):531-7. (PMID: 19752010)
      Schizophr Res. 2018 Sep;199:333-340. (PMID: 29526453)
      Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:235-242. (PMID: 30707986)
      BMC Psychiatry. 2022 May 27;22(1):360. (PMID: 35624473)
      Acta Psychiatr Scand. 2005 Nov;112(5):351-9. (PMID: 16223422)
      JAMA Psychiatry. 2015 Mar;72(3):259-67. (PMID: 25607833)
      Psychol Med. 2015 Apr;45(6):1277-88. (PMID: 25273550)
      Nat Rev Drug Discov. 2012 Feb 01;11(2):141-68. (PMID: 22293568)
      Schizophr Bull. 2012 Mar;38(2):247-57. (PMID: 22258882)
      Int J Environ Res Public Health. 2020 Jan 08;17(2):. (PMID: 31936285)
      BMC Psychiatry. 2014 Jun 05;14:166. (PMID: 24903304)
      Psychiatry Res. 2020 Sep;291:113254. (PMID: 32603930)
      Perspect Psychiatr Care. 2022 Oct;58(4):2872-2880. (PMID: 35767392)
      BMC Psychiatry. 2019 Dec 27;19(1):421. (PMID: 31881985)
      Perspect Psychiatr Care. 2022 Jan;58(1):304-313. (PMID: 33821486)
      Sleep. 2016 May 01;39(5):1111-20. (PMID: 26951391)
      Schizophr Bull. 2018 Aug 20;44(5):1111-1122. (PMID: 29301025)
      Int J Bipolar Disord. 2016 Dec;4(1):2. (PMID: 26763504)
      Int J Psychiatry Clin Pract. 2020 Sep;24(3):270-277. (PMID: 32228282)
      Eur Psychiatry. 2015 Sep;30(6):665-80. (PMID: 26078093)
      Front Psychiatry. 2017 Jun 01;8:92. (PMID: 28620323)
      BMC Pediatr. 2021 Jun 22;21(1):288. (PMID: 34158020)
      Front Med (Lausanne). 2020 Aug 13;7:447. (PMID: 32903556)
      J Affect Disord. 2018 Mar 1;228:41-48. (PMID: 29223913)
      Schizophr Res. 2018 Mar;193:204-208. (PMID: 28711475)
      Front Psychiatry. 2022 Sep 20;13:1011963. (PMID: 36203842)
      Acta Psychiatr Scand. 2013 Nov;128(5):327-46. (PMID: 23379898)
      Clin Psychol Rev. 2016 Nov;49:92-105. (PMID: 27632064)
      World Psychiatry. 2016 Feb;15(1):41-52. (PMID: 26833608)
      Gen Hosp Psychiatry. 2018 Mar - Apr;51:15-21. (PMID: 29268166)
      Prim Care Companion CNS Disord. 2020 May 14;22(3):. (PMID: 32408399)
      JAMA Netw Open. 2018 Nov 2;1(7):e184493. (PMID: 30646356)
      Dement Geriatr Cogn Dis Extra. 2018 Mar 20;8(1):98-103. (PMID: 29706986)
      Int J Ment Health Addict. 2021;19(6):2219-2232. (PMID: 32427217)
      World Psychiatry. 2021 Feb;20(1):107-123. (PMID: 33432756)
      Front Neurosci. 2019 Mar 21;13:274. (PMID: 30983960)
      BMC Psychiatry. 2013 Jan 09;13:15. (PMID: 23302219)
      Front Psychol. 2020 Jul 31;11:1632. (PMID: 32903697)
      Child Abuse Negl. 2020 Dec;110(Pt 2):104694. (PMID: 32900515)
      Front Psychiatry. 2019 Apr 18;10:261. (PMID: 31057446)
      Compr Psychiatry. 2013 Feb;54(2):123-7. (PMID: 22901835)
      Psychol Med. 2011 Nov;41(11):2339-48. (PMID: 21557896)
      Psychol Trauma. 2020 Jul;12(5):546-549. (PMID: 32538654)
      Ir J Psychol Med. 2015 Mar;32(1):21-30. (PMID: 30185274)
      Ann Neurosci. 2013 Oct;20(4):157-61. (PMID: 25206042)
    • Contributed Indexing:
      Keywords: Anxiety; Depression; Distress; Positive psychotic symptoms; Schizophrenia; Trauma
    • الموضوع:
      Date Created: 20230112 Date Completed: 20230116 Latest Revision: 20230206
    • الموضوع:
      20230207
    • الرقم المعرف:
      PMC9835034
    • الرقم المعرف:
      10.1186/s12888-023-04531-3
    • الرقم المعرف:
      36635691